← Browse by Condition
Medical Condition
primary central nervous system lymphoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2, Phase 2
NCT05351593 Phase 1, Phase 2
Recruiting
Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma
Enrollment
35 pts
Location
United States
Sponsor
James Rubenstein
NCT07350850 Phase 2
Recruiting
A Multicenter Two-Cohort Study of Methotrexate, Rituximab, Sintilimab and Pirtobrutinib for Treatment-Naive PCNSL vs. Real-World Investigator-Selected Treatment (Observational Cohort)
Enrollment
110 pts
Location
China
Sponsor
Tongji Hospital